Lemaitre Vascular (LMAT) Operating Income (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Operating Income of $17.8 million for Q1 2026, up 40.78% year-over-year from $12.6 million in Q1 2025, and down 5.61% quarter-over-quarter from $18.8 million in Q4 2025.
Lemaitre Vascular (LMAT) Operating Income (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Operating Income for 17 consecutive years, with $17.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 40.78% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $73.1 million (up 37.83% YoY), while the FY2025 annual figure was $67.9 million, up 29.96% from the prior year.
- Operating Income eased to $17.8 million in Q1 2026 per LMAT's latest filing, from $18.8 million in the prior quarter.
- Across five years, Operating Income topped out at $20.3 million in Q3 2025 and bottomed at $5.8 million in Q2 2022.
- Historically, Operating Income has averaged $11.9 million across 5 years, with a median of $11.9 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Income sank 47.92% — and 2023, when it soared 63.42%.
- Lemaitre Vascular's Operating Income stood at $7.0 million in 2022, then jumped by 46.49% to $10.2 million in 2023, then increased by 25.95% to $12.9 million in 2024, then soared by 46.51% to $18.8 million in 2025, then retreated by 5.61% to $17.8 million in 2026.
- Business Quant data shows LMAT's Operating Income at $17.8 million in Q1 2026, $18.8 million in Q4 2025, and $20.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.05 Bn | 128.83 Bn | 1.96 Bn | 971.90 Mn |
| 2 | Becton Dickinson | 52.50 Bn | 51.64 Bn | 2.32 Bn | 663.00 Mn |
| 3 | Alcon | 35.70 Bn | 34.34 Bn | 1.68 Bn | 11.00 Mn |
| 4 | Resmed | 33.66 Bn | 32.19 Bn | 861.22 Mn | 448.71 Mn |
| 5 | Medline | 29.16 Bn | 26.49 Bn | 2.22 Bn | 395.00 Mn |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn | 179.10 Mn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 181.00 Mn |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | -31.00 Mn |
| 9 | Baxter International | 13.50 Bn | 11.35 Bn | 1.03 Bn | 217.00 Mn |
| 10 | Lemaitre Vascular | 1.87 Bn | 1.50 Bn | 50.76 Mn | 20.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.40 Mn |
| Mar 31, 2026 | 17.78 Mn |
| Dec 31, 2025 | 18.83 Mn |
| Sep 30, 2025 | 20.31 Mn |
| Jun 30, 2025 | 16.14 Mn |
| Mar 31, 2025 | 12.63 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 13.15 Mn |
| Jun 30, 2024 | 14.38 Mn |
| Mar 31, 2024 | 11.87 Mn |
| Dec 31, 2023 | 10.21 Mn |
| Sep 30, 2023 | 9.18 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | 6.15 Mn |
| Jun 30, 2022 | 5.78 Mn |
| Mar 31, 2022 | 7.93 Mn |
| Dec 31, 2021 | 8.30 Mn |
| Sep 30, 2021 | 9.07 Mn |